Hunan Hansen Pharmaceutical Co Ltd
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syru… Read more
Hunan Hansen Pharmaceutical Co Ltd (002412) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.023x
Based on the latest financial reports, Hunan Hansen Pharmaceutical Co Ltd (002412) has a cash flow conversion efficiency ratio of 0.023x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.51 Million) by net assets (CN¥2.26 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hunan Hansen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Hunan Hansen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hunan Hansen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Hansen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rainbow Tours SA
WAR:RBW
|
0.323x |
|
Hyliion Holdings Corp.
NYSE MKT:HYLN
|
-0.052x |
|
thyssenkrupp nucera AG & Co. KGaA
OTCGREY:THYKF
|
0.001x |
|
Dr. Hönle AG
OTCGREY:DRHNF
|
0.038x |
|
Hubei Mailyard Share Co Ltd
SHG:600107
|
0.009x |
|
Cabio Biotech Wuhan Co Ltd
SHG:688089
|
0.034x |
|
Fox-Wizel Ltd
PINK:FXWZF
|
0.112x |
|
TRANSILVANIA INVESTMENTS ALLIANCE S.A.
RO:TRANSI
|
N/A |
Annual Cash Flow Conversion Efficiency for Hunan Hansen Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.20 Billion | CN¥130.78 Million | 0.059x | -27.60% |
| 2023-12-31 | CN¥1.96 Billion | CN¥160.95 Million | 0.082x | +7.99% |
| 2022-12-31 | CN¥1.89 Billion | CN¥143.81 Million | 0.076x | -37.76% |
| 2021-12-31 | CN¥1.74 Billion | CN¥212.54 Million | 0.122x | +19.95% |
| 2020-12-31 | CN¥1.59 Billion | CN¥162.19 Million | 0.102x | -5.76% |
| 2019-12-31 | CN¥1.53 Billion | CN¥165.11 Million | 0.108x | -32.36% |
| 2018-12-31 | CN¥1.36 Billion | CN¥217.52 Million | 0.160x | +81.50% |
| 2017-12-31 | CN¥1.22 Billion | CN¥107.18 Million | 0.088x | -31.35% |
| 2016-12-31 | CN¥1.26 Billion | CN¥161.16 Million | 0.128x | +152.48% |
| 2015-12-31 | CN¥1.25 Billion | CN¥63.57 Million | 0.051x | -31.23% |
| 2014-12-31 | CN¥1.15 Billion | CN¥85.05 Million | 0.074x | +7.35% |
| 2013-12-31 | CN¥1.11 Billion | CN¥76.09 Million | 0.069x | -33.85% |
| 2012-12-31 | CN¥965.11 Million | CN¥100.23 Million | 0.104x | +70.44% |
| 2011-12-31 | CN¥883.65 Million | CN¥53.84 Million | 0.061x | +157.83% |
| 2010-12-31 | CN¥898.82 Million | CN¥21.24 Million | 0.024x | -89.66% |
| 2009-12-31 | CN¥179.51 Million | CN¥41.02 Million | 0.228x | -12.30% |
| 2008-12-31 | CN¥130.26 Million | CN¥33.94 Million | 0.261x | -39.43% |
| 2007-12-31 | CN¥87.77 Million | CN¥37.75 Million | 0.430x | -- |